stockrowMesoblast Limited (MESO) vs Sarepta Therapeutics, Inc. (SRPT)
- Mesoblast Limited MESO 14.23 +0.92%
- Sarepta Therapeutics, Inc. SRPT 17.71 +0.80%
Mesoblast Limited and Sarepta Therapeutics, Inc. are both Biotechnology companies. Mesoblast Limited and Sarepta Therapeutics, Inc. are of similar size ($1.9B and $1.8B). Sarepta Therapeutics, Inc. grew revenue faster over the last twelve months: −19.0% against −26.5%. Sarepta Therapeutics, Inc. has the higher net margin (−5.86% vs −1,091.7%) and the lower return on invested capital (−2.03% vs 0.00%). Across the 18 metrics below, Sarepta Therapeutics, Inc. leads on 11 and Mesoblast Limited on 7.
Valuation
Profitability
| Metric | MESO | SRPT | Biotechnology median |
|---|---|---|---|
| Gross margin | (269.72%) | 0.00% | 68.51% |
| Operating margin | (826.28%) | (2.50%) | 0.00% |
| Net margin | (1,091.71%) | (5.86%) | 0.00% |
| Free cash flow margin | 0.00% | 9.02% | 0.00% |
| Return on equity | 0.00% | (8.05%) | (51.96%) |
| Return on assets | 0.00% | (3.44%) | (46.06%) |
| Return on invested capital | 0.00% | (2.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack